Ana Martin-Blanco
Overview
Explore the profile of Ana Martin-Blanco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin-Blanco A, Gonzalez-Fernandez A, Farre A, Sague-Vilavella M, Vieira S, Gimenez D, et al.
Community Ment Health J
. 2024 Feb;
60(5):1025-1030.
PMID: 38424398
Intensive home treatment (IHT) has shown to be a feasible alternative to hospitalization for the management of acute psychiatric episodes, but there are no real-world studies assessing if patients with...
2.
Alemany C, Puigdemont D, Martin-Blanco A, Rodriguez-Rodriguez R, Aibar-Duran J, Vicent-Gil M, et al.
J Clin Psychiatry
. 2023 Jun;
84(4).
PMID: 37378475
To replicate previous findings and to investigate related clinical factors of long-term benefits and safety of subcallosal cingulate gyrus deep brain stimulation (SCG-DBS) for treatment-resistant depression (TRD). Sixteen patients with...
3.
Martin-Blanco A, Calvo-Saiz L, Baccarin J, Gonzalez-Fernandez A, Keymer-Gausset A, Vieira-Costa S, et al.
Rev Psiquiatr Salud Ment (Engl Ed)
. 2022 Oct;
15(3):213-215.
PMID: 36272741
No abstract available.
4.
Soler J, Casellas-Pujol E, Fernandez-Felipe I, Martin-Blanco A, Almenta D, Pascual J
Acta Psychiatr Scand
. 2022 Jan;
145(4):332-342.
PMID: 35088405
Objective: Polypharmacy and overprescription of off-label medications are common in patients with borderline personality disorder (BPD). The aim of the present naturalistic study was to explore whether the skills training...
5.
Pascual J, Martin-Blanco A, Soler J
CNS Drugs
. 2021 Aug;
35(9):1023-1032.
PMID: 34370282
Objective: Although no psychotropic drugs have been officially approved for the treatment of borderline personality disorder (BPD), medications are routinely prescribed for these patients. The primary aim of this study...
6.
Casellas E, Raventos B, Pineiro-Rios M, Navarro-Martinez H, Castillon-Espezel M, Portella M, et al.
Int J Environ Res Public Health
. 2021 Jun;
18(9).
PMID: 34068535
Although pharmacotherapy is considered the first-line treatment for bipolar disorders (BD), adjunctive psychoeducation has proven its effectiveness in improving self-management of the disease and reducing relapse rates. Few studies have...
7.
Arranz M, Gallego-Fabrega C, Martin-Blanco A, Soler J, Elices M, Dominguez-Clave E, et al.
Transl Psychiatry
. 2021 Jan;
11(1):5.
PMID: 33414392
Borderline personality disorder (BPD) is a severe and highly prevalent psychiatric disorder, more common in females than in males and with notable differences in presentation between genders. Recent studies have...
8.
Aguilar-Ortiz S, Salgado-Pineda P, Vega D, Pascual J, Marco-Pallares J, Soler J, et al.
Psychol Med
. 2019 Aug;
50(10):1746-1754.
PMID: 31456534
Background: Although executive and other cognitive deficits have been found in patients with borderline personality disorder (BPD), whether these have brain functional correlates has been little studied. This study aimed...
9.
Carmona I Farres C, Elices M, Soler J, Dominguez-Clave E, Martin-Blanco A, Pomarol-Clotet E, et al.
Clin Psychol Psychother
. 2019 May;
26(5):562-571.
PMID: 31132302
Patients with borderline personality disorder (BPD) present dysfunctions of the default mode network (DMN). Mindfulness training has proven effective to improve the symptoms of BPD. The present study examines the...
10.
Elices M, Pascual J, Carmona C, Martin-Blanco A, Feliu-Soler A, Ruiz E, et al.
BMC Psychiatry
. 2018 Sep;
18(1):284.
PMID: 30180825
In the original publication of this article [1] the funding acknowledgement for grant "PI13/00134, ERDF Funds" was missing.